| Application no. and date | 02726733.5 (espacenet) (Federated) (European Patent Register), 20020410 | | Patent/reg. no. and date | DK/EP 1392331, 20080402 | | Publication date | 20040303 | | Priority no. and date | US 284445 P, 20010418, US 305564 P, 20010713 | | EP pub. no. and date |
EP 1392331 20040303 | | Effective date | | | Applicant/owner | Genzyme Corporation, 500 Kendall Street
Cambridge, MA 02142, US | | Applicant ref. no. | 151962 | | Inventor | BURKE, Steven, K., 82 Willis Road
Sudbury, MA 01776, US,
Joanne M. DONOVAN, 47 Thornton Road
Needham, Massachusetts 02492, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/785 (2006.01) , A61P 3/10 (2006.01) | | Title | Anvendelse af colesevelam eller sevelamer, hydrogenchlorid til sænkning af serumglucoseniveauet | | Int. application no. | US2002011493 | | Int. publication no. | WO2002085377 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
